Literature DB >> 10320228

Pleurodesis by autologous blood, doxycycline, and talc in a rabbit model.

R E Mitchem1, B L Herndon, R M Fiorella, A Molteni, C N Battie, G R Reisz.   

Abstract

BACKGROUND: Management of recurrent spontaneous pneumothorax or symptomatic pleural effusion often uses thoracoscopic pleurodesis, about which many questions remain. Both effectiveness and toxicity of agents currently used for pleurodesis were evaluated in a rabbit model.
METHODS: Agents administered were autologous blood 1 mL/kg, talc slurry (70 mg x mL(-1) x kg(-1)), and doxycycline 10 mg/mL, given through a chest tube to 30 rabbits. Controls had only chest tubes inserted. At 30 days surfaces were graded by gross observation and histologic examination. Blood and lung tissue from all animals were analyzed for enzymes and blood chemistries.
RESULTS: Gross observations showed mediastinal thickening and adhesions with doxycycline, and threadlike adhesions with talc. Autologous blood was only slightly more effective than a chest tube alone. Talc significantly increased angiotensin converting enzyme activity in serum, whereas doxycycline changed liver function enzymes and produced tissue toxicity.
CONCLUSIONS: Doxycycline produced effective pleurodesis but yielded remarkably severe local effects. The distant sequelae of talc and doxycycline pleurodesis-histologic changes in the contralateral lung and serum enzyme elevations-suggests undesirable systemic effects for the commonly used agents, and autologous blood exhibited no significant pleurodesis, short-term. The search for the ideal agent for chemical pleurodesis continues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10320228     DOI: 10.1016/s0003-4975(99)00160-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  16 in total

1.  Experimental validation of talc pleurodesis for carcinomatous pleuritis in an animal model.

Authors:  Yasunori Iwasaki; Shinzo Takamori; Masahiro Mitsuoka; Masaki Kashihara; Tatsuya Nishi; Daigo Murakami; Ryoichi Matsumoto; Hiroharu Mifune; Yuji Tajiri; Yoshito Akagi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-05-12

2.  Polidocanol at different concentrations for pleurodesis in rats.

Authors:  Bahadir Cetin; E Arzu Koçkaya; Can Atalay; M Turan Akay
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

3.  Successful use of blood pleurodesis to resolve an iatrogenic persistent pneumothorax in a patient with pulmonary tuberculosis.

Authors:  Masooma Shaukat; Catherine Hyams; Vladimir M Macavei; Terence C O'Shaughnessy
Journal:  BMJ Case Rep       Date:  2014-09-19

4.  Changes in the pleural cavity by pleurodesis using talc or OK-432: an experimental study.

Authors:  Fumihiko Muta; Shinzo Takamori; Toshihiro Matsuo; Yasunori Iwasaki; Koichi Yoshiyama; Kazuo Shirouzu
Journal:  Surg Today       Date:  2010-12-30       Impact factor: 2.549

5.  Transforming growth factor beta(2) (TGF beta(2)) produces effective pleurodesis in sheep with no systemic complications.

Authors:  Y C Lee; K B Lane; R E Parker; D S Ayo; J T Rogers; R W Diters; P J Thompson; R W Light
Journal:  Thorax       Date:  2000-12       Impact factor: 9.139

Review 6.  Malignant pleural effusions: appropriate treatment approaches.

Authors:  Yener Aydin; Atila Turkyilmaz; Yavuz Selim Intepe; Atilla Eroglu
Journal:  Eurasian J Med       Date:  2009-12

Review 7.  Treating Recurrent Pleural Disease: A Review of Indications and Technique for Chemical Pleurodesis for the Interventional Radiologist.

Authors:  Surbhi B Trivedi; Matthew Niemeyer
Journal:  Semin Intervent Radiol       Date:  2022-08-31       Impact factor: 1.780

8.  Autologous blood pleurodesis: A good choice in patients with persistent air leak.

Authors:  Ufuk Cobanoglu; Mehmet Melek; Yesim Edirne
Journal:  Ann Thorac Med       Date:  2009-10       Impact factor: 2.219

9.  Intrapleural instillation of autologous blood for persistent air leak in spontaneous pneumothorax- is it as effective as it is safe?

Authors:  Dimos Karangelis; Georgios I Tagarakis; Marios Daskalopoulos; Georgios Skoumis; Nicholaos Desimonas; Vasileios Saleptsis; Theocharis Koufakis; Athanasios Drakos; Dimitrios Papadopoulos; Nikolaos B Tsilimingas
Journal:  J Cardiothorac Surg       Date:  2010-08-17       Impact factor: 1.637

10.  Pleurodesis by erythromycin, tetracycline, Aerosil™ 200, and erythromycin plus Aerosil™ 200 in a rat model: a preliminary study.

Authors:  Shahryar Hashemzadeh; Khosrow Hashemzadeh; Kamran Mamaghani; Elnaz Ansari; Raheleh Aligholipour; Samad Ej Golzari; Kamyar Ghabili
Journal:  Daru       Date:  2012-11-26       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.